Crescom Launches Pediatric MSK AI Validation Study with Mass General Brigham

Crescom and Mass General Brigham have launched a clinical validation study for an AI tool targeting pediatric musculoskeletal imaging. Study design, endpoints, and timeline were not disclosed, and no performance data are yet available.

• Announcement of a validation partnership between Crescom and Mass General Brigham for a pediatric musculoskeletal AI tool.
• No details on sample size, study endpoints, or expected completion were provided at this time.
• This is an early-stage industry–academic collaboration; no regulatory status or clinical performance claims can be inferred.

RadPigeon summaries are original and for information only. They are not clinical advice.